Effects of erdosteine on bleomycin-induced lung fibrosis in rats
✍ Scribed by Haşim Boyacı; Hale Maral; Gupse Turan; İlknur Başyiğit; Meltem Ö. Dillioğlugil; Füsun Yıldız; Melih Tugay; Ayşe Pala; Cengiz Erçin
- Publisher
- Springer
- Year
- 2006
- Tongue
- English
- Weight
- 905 KB
- Volume
- 281
- Category
- Article
- ISSN
- 0300-8177
No coin nor oath required. For personal study only.
📜 SIMILAR VOLUMES
## Abstract The usefulness of doxorubicin (DXR) is limited by its cardiotoxicity. In order to improve future DXR therapy by using a new antioxidant agent, an experimental study was designed. This study was undertaken to determine whether DXR‐induced cardiotoxicity is prevented by erdosteine, a muco
## Abstract Although different treatment modalities have been implemented for pulmonary fibrosis, the results have not been promising and these conditions have been considered untreatable and irreversible. Thus, a plethora of new drugs has been tried for the control of this condition in recent year
Bleomycin is an antibiotic used to treat a variety of neoplasms. A major side-effect of bleomycin therapy is the induction of an intense inflammatory response that develops into pulmonary fibrosis. Several studies have shown that certain polyunsaturated fatty acids found in fish oil reduce the infla